Anavex Life Sciences (AVXL) Net Cash Flow (QoQ) (2010 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Anavex Life Sciences | 266.20 Mn | 134.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,964.54% |
| Sep 30, 2025 | 109.67% |
| Jun 30, 2025 | -191.91% |
| Mar 31, 2025 | 56.15% |
| Dec 31, 2024 | -73.73% |
| Sep 30, 2024 | -942.70% |
| Jun 30, 2024 | 85.61% |
| Mar 31, 2024 | 39.67% |
| Dec 31, 2023 | -91.38% |
| Sep 30, 2023 | -380.96% |
| Jun 30, 2023 | -86.29% |
| Mar 31, 2023 | 277.84% |
| Dec 31, 2022 | -36.98% |
| Sep 30, 2022 | -2,722.27% |
| Jun 30, 2022 | -106.52% |
| Mar 31, 2022 | 328.44% |
| Dec 31, 2021 | 82.37% |
| Sep 30, 2021 | -106.67% |
| Jun 30, 2021 | 186.65% |
| Mar 31, 2021 | 57.39% |
| Dec 31, 2020 | 1,011.04% |
| Sep 30, 2020 | 54.33% |
| Jun 30, 2020 | 217.95% |
| Mar 31, 2020 | -116.98% |
| Dec 31, 2019 | 463.08% |
| Sep 30, 2019 | -47.73% |
| Jun 30, 2019 | 242.47% |
| Mar 31, 2019 | 43.25% |
| Dec 31, 2018 | 23.52% |
| Sep 30, 2018 | -1,794.05% |
| Jun 30, 2018 | 107.15% |
| Mar 31, 2018 | -493.18% |
| Dec 31, 2017 | -77.01% |
| Sep 30, 2017 | 83.57% |
| Jun 30, 2017 | -34.16% |
| Mar 31, 2017 | -81.71% |
| Dec 31, 2016 | 2,316.60% |
| Sep 30, 2016 | 75.71% |
| Jun 30, 2016 | -16.89% |
| Mar 31, 2016 | -32.35% |
| Dec 31, 2015 | -119.61% |
| Sep 30, 2015 | 344.04% |
| Jun 30, 2015 | 346.27% |
| Mar 31, 2015 | -138.35% |
| Dec 31, 2014 | 69.35% |
| Sep 30, 2014 | 9.50% |
| Jun 30, 2014 | -111.14% |
| Mar 31, 2014 | 3,751.51% |
| Dec 31, 2013 | -172.55% |
| Sep 30, 2013 | 29,557.08% |
| Jun 30, 2013 | 101.46% |
| Mar 31, 2013 | -215.89% |
| Dec 31, 2012 | 1,101.42% |
| Sep 30, 2012 | 95.74% |
| Jun 30, 2012 | -194.62% |
| Mar 31, 2012 | 234.98% |
| Dec 31, 2011 | 88.45% |
| Sep 30, 2011 | -189.25% |
| Jun 30, 2011 | 390.14% |
| Mar 31, 2011 | -364.05% |
| Dec 31, 2010 | 113.37% |